RxDoctor Payments Data

Brittany Buckmaster, PA

Surgical · Dallas, TXNPI 1053714618

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medical Device Business Services, Inc. at 52.0% of the total. Reporting peaked in 2022 at $3,237 and has fallen 84.8% since, to $490 in 2025. Among surgical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,552in general payments, 2019–2025

Across 58 payments — averaging $112.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$3K
  • Enterra Medical, Inc.$1K
  • Intuitive Surgical$405
  • Johnson & Johnson$391
  • AbbVie$218
  • Davol Inc.$216
  • plus $684 from 9 others

What the payments were for

  • Consulting fees$3,30050%
  • Travel & lodging$2263%
  • Food & beverage$3,02646%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,552 in reported general payments places this provider in the 95th percentile of 804 surgical providers in Texas.

See all surgical providers in Texas

Medicare billing

Part B allowed, 2024
$16,627
Medicare patients
94
Services billed
140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GimotiMetoclopramide Hcl14$28,176
Sucralfate34$4,638
Dexlansoprazole DrDexlansoprazole11$3,391
Esomeprazole Magnesium15$1,457
Omeprazole95$870
Pantoprazole Sodium63$433
Metoclopramide Hcl37$367
Ondansetron OdtOndansetron17$154
Amitriptyline Hcl16$63

Paid to pharmacies, not to this prescriber.

Other surgical in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →